Literature DB >> 10682929

Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining.

N Sato1, M Suzuki, N Kuwata, K Kuroda, T Wada, T Beppu, K Sera, T Sasaki, A Ogawa.   

Abstract

11C-methionine positron emission tomography (PET) and proliferating cell nuclear antigen (PCNA) staining were performed in 13 cases of glioma to investigate the relationship between the uptake of L-[methyl]-11C-methionine and the degree of malignancy and proliferative potential. The 11C-methionine uptake was significantly greater in high-grade gliomas compared to low-grade gliomas (P<0.05). The PCNA indexes were also significantly higher in the high-grade cases (P<0.05). Moreover, a strong positive correlation was found between the 11C-methionine values and the PCNA indexes (P<0.005), demonstrating that higher 11C-methionine uptake was associated with greater proliferative potential and greater malignancy. 11C-methionine PET is a potentially useful preoperative method to discriminate the malignancy of glioma.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10682929     DOI： 10.1007/s101430050018

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


  34 in total

1.  Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.

Authors:  Christina I Tsien; Doris Brown; Daniel Normolle; Matthew Schipper; Morand Piert; Larry Junck; Jason Heth; Diana Gomez-Hassan; Randall K Ten Haken; Thomas Chenevert; Yue Cao; Theodore Lawrence
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.

Authors:  Dan Ribom; Marjoleine Schoenmaekers; Henry Engler; Anja Smits
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 3.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

4.  Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.

Authors:  Osamu Manabe; Naoya Hattori; Shigeru Yamaguchi; Kenji Hirata; Kentaro Kobayashi; Shunsuke Terasaka; Hiroyuki Kobayashi; Hiroaki Motegi; Tohru Shiga; Keiichi Magota; Noriko Oyama-Manabe; Ken-ichi Nishijima; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

5.  [11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms.

Authors:  D S Rosenberg; G Demarquay; A Jouvet; D Le Bars; N Streichenberger; M Sindou; N Kopp; F Mauguière; P Ryvlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 6.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.

Authors:  Y Waerzeggers; R T Ullrich; P Monfared; T Viel; M Weckesser; W Stummer; O Schober; A Winkeler; A H Jacobs
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

7.  O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.

Authors:  Gengo Yamaura; Takashi Yoshioka; Hiroshi Fukuda; Keichiro Yamaguchi; Manami Suzuki; Shozo Furumoto; Ren Iwata; Chikashi Ishioka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

8.  High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy.

Authors:  Akira Sudo; Tohru Shiga; Maki Okajima; Kyoko Takano; Satoshi Terae; Yutaka Sawamura; Akiko Ohnishi; Kazuo Nagashima; Shinji Saitoh
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

9.  Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Authors:  Takeko Nojiri; Tadashi Nariai; Masaru Aoyagi; Michio Senda; Kenji Ishii; Kiichi Ishiwata; Kikuo Ohno
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

10.  [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.

Authors:  Norbert Galldiks; Lutz W Kracht; Frank Berthold; Hrvoje Miletic; Johannes C Klein; Karl Herholz; Andreas H Jacobs; Wolf-Dieter Heiss
Journal:  J Neurooncol       Date:  2009-07-04       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.